ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,446Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 288

$445K Total Retail Price of All Prescriptions

Rank: 98 out of 288

491 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 491 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 491 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,641 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 655 598 1 1
LEVOTHYROXINE SODIUM 398 377 2 2
OMEPRAZOLE 332 329 3 3
LISINOPRIL 325 301 4 4
AMLODIPINE BESYLATE 307 292 5 6
METOPROLOL TARTRATE 244 220 6 8
HYDROCHLOROTHIAZIDE 224 219 7 13
METFORMIN HCL 221 185 8 12
WARFARIN SODIUM 211 206 9 9
PRAVASTATIN SODIUM 190 180 10 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 183 165 11 34
ZOLPIDEM TARTRATE 173 155 12 22
LOSARTAN POTASSIUM 167 166 13 16
POTASSIUM CHLORIDE 165 159 14 11
ATORVASTATIN CALCIUM 147 145 15 14
SERTRALINE HCL 142 116 16 25
FUROSEMIDE 128 128 17 5
HYDROCODONE-ACETAMINOPHEN 118 113 S3 18 7
CARVEDILOL 115 115 19 27
ALENDRONATE SODIUM 111 102 20 20
ALLOPURINOL 101 89 21 23
METOPROLOL SUCCINATE 100 96 22 15
BENAZEPRIL HCL 95 82 23 52
GLIMEPIRIDE 95 82 23 32
CITALOPRAM HBR 94 76 25 18
LANTUS 91 91 26 31
GABAPENTIN 89 79 27 17
FLUTICASONE PROPIONATE 88 78 28 41
ZETIA 73 70 29 58
TRAMADOL HCL 72 59 30 19
ADVAIR DISKUS 68 67 31 50
TAMSULOSIN HCL 65 65 32 24
MORPHINE SULFATE ER 64 46 S2 33 131
HUMALOG 64 60 33 117
PEN NEEDLE 62 57 35 100
SPIRONOLACTONE 61 58 36 36
DIOVAN 59 59 37 53
VENLAFAXINE HCL ER 56 55 38 94
ATENOLOL 54 49 39 10
DILTIAZEM 24HR CD 51 51 40 75
FENTANYL 51 51 S2 40 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.